Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 300 of 1229 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 05/25/21
End: 09/16/21
Due: 09/16/22
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 06/13/22
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 12/01/17
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 05/20/24
End: 05/20/34
Due: 05/20/35
Phase: N/A
Priority: Normal
Start: 01/08/16
End: 05/02/16
Due: 05/02/17
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 07/31/16
Due: 07/31/17
Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 05/12/21
End: 09/01/24
Due: 09/01/25
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 03/31/07
Due: 03/31/08
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 11/30/14
Due: 11/30/15